AU Patent

AU2015204192B2 — Dosage regimen of ferric trimaltol

Assigned to Shield Tx UK Ltd · Expires 2020-03-26 · 6y expired

What this patent protects

The present invention relates to a dosage regimen of ST10 (ferric trimaltol) for the treatment of patients suffering from iron deficiency with or without anaemia. Specifically the invention relates to the treatment of patients with 30mg ST10 twice daily.

USPTO Abstract

The present invention relates to a dosage regimen of ST10 (ferric trimaltol) for the treatment of patients suffering from iron deficiency with or without anaemia. Specifically the invention relates to the treatment of patients with 30mg ST10 twice daily.

Drugs covered by this patent

Patent Metadata

Patent number
AU2015204192B2
Jurisdiction
AU
Classification
—
Expires
2020-03-26
Drug substance claim
No
Drug product claim
No
Assignee
Shield Tx UK Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.